Ticker
STIMCompany Name
NEURONETICS INCSector
HealthcareIndustry
Diagnostics & ResearchExchange
NASDAQDate | Market Capitalization | Net Cash Flow - Issuance (Purchase) of Equity Shares | Net Cash Flow - Issuance (Repayment) of Debt Securities | Net Cash Flow - Dividends & Other Cash Distributions | Shareholder Yield |
---|---|---|---|---|---|
6/30/2025 | $ 300.54M | $ 21.5M | $ -9.33M | $ 0 | -4.05% |
3/31/2025 | $ 296.19M | $ 21.5M | $ -9.33M | $ 0 | -4.11% |
12/31/2024 | $ 263.26M | $ 2.52M | $ -9.33M | $ 0 | 2.59% |
9/30/2024 | $ 20.94M | $ 1.92M | $ 3.97M | $ 0 | -28.12% |
6/30/2024 | $ 22.57M | $ 1K | $ 22.26M | $ 0 | -98.63% |
3/31/2024 | $ 77.99M | $ 1K | $ 22.2M | $ 0 | -28.46% |
12/31/2023 | $ 122.59M | $ 1K | $ 22.7M | $ 0 | -18.51% |
9/30/2023 | $ 40.51M | $ 246K | $ 436K | $ 0 | -1.68% |
6/30/2023 | $ 54.57M | $ 246K | $ 436K | $ 0 | -1.25% |
3/31/2023 | $ 80.37M | $ 289K | $ 465K | $ 0 | -0.94% |
We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue
(-1 * CF - Equity -1 * CF - Dividends -1 * CF - Debt) / Market Cap
(=) Shareholder Yield
Shareholder Yield for NEURONETICS INC is calculated as follows: (-1 * CF - Equity [ $ 634K ] -1 * CF - Dividends [ $ 0 ] -1 * CF - Debt [ $ 1.78M ]) / Market Cap [ $ 99.05M ]
(=) Shareholder Yield [ -2.44% ]
Minimum
Dec 31, 2021
Maximum
Dec 31, 2024
Average
Median
filtered constituents | 3.48K |
---|---|
min | -33.43% |
max | 34.45% |
average | 0.57% |
median | 1.07% |
std | 11.13% |